Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cipla
Healthtrust
Colorcon
Fish and Richardson
Daiichi Sankyo
Baxter
QuintilesIMS
Julphar

Generated: June 22, 2018

DrugPatentWatch Database Preview

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Calcipotriene And Betamethasone Dipropionate, and when can generic versions of Calcipotriene And Betamethasone Dipropionate launch?

Calcipotriene And Betamethasone Dipropionate is a drug marketed by Perrigo Israel and Tolmar and is included in two NDAs.

The generic ingredient in CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE is betamethasone dipropionate; calcipotriene hydrate. There are sixty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene hydrate profile page.
Summary for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Drug patent expirations by year for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Pharmacology for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Synonyms for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
485805-18-3
Betamethasone dipropionate and calcipotriene
Betamethasone dipropionate mixture with calcipotriene
Betamethasone dipropionate-calcipotriene mixt.
Calcipotriol/betamethasone dipropionate
D0FW2A
Daivobet
Dovobet
Enstilar
LEO 80185
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11beta,16beta)-, mixt. with (1alpha,3beta,5Z,7E,22E,24S)-24-cyclopropyl-9,10-secochola- 5,7,10(19),22-tetraene-1,3,24-triol
SCHEMBL18863209
Taclonex scalp
Xamiol

US Patents and Regulatory Information for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Israel CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene hydrate OINTMENT;TOPICAL 200174-001 Dec 12, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Tolmar CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene hydrate OINTMENT;TOPICAL 201615-001 Jan 14, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Argus Health
Boehringer Ingelheim
Covington
Baxter
US Army
Citi
QuintilesIMS
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.